Status: Not yet recruiting
Real-World Efficacy and Safety of Tenapanor Plus Phosphate Binders in Hemodialysis Patients With Hyperphosphatemia
The efficacy and safety of tenapanor plus PBs in Chinese patients are still unclear. Therefore, we aim to conduct a real-world study to explore the effect of combining two drugs with different mechanisms on hyperphosphatemia management.This real-world study will enroll hemodialysis patients with hyperphosphatemia who are on PBs therapy.
Participants needed: 200
Trial details
Age: 18-100Biological sex: AllType: ObservationalSponsor: Peking University People's HospitalUpdated: Aug 20, 2026Locations: 1Duration: 6 Months
Eligibility criteria
The subject has provided written informed consent prior to the initiation of any... [+4]
Hypersensitivity to Tenapanor or any excipients of the formulation. [+5]